As Clinical Lead of the Psilocybin for Depression Study at Imperial College London, Dr Rosalind Watts led the clinical team which facilitated over a hundred psilocybin therapy sessions in just over a year. She has published qualitative research into the psychological mechanisms of psilocybin treatment, and a model of psychedelic therapy- ‘Accept, Connect, Embody (ACE)’. Ros has designed a validated psychometric tool for measuring 'general connectedness'- an expanded state which includes connectedness to self, others, and the natural world. In her current role as Clinical Director of Synthesis Institute, she is leading the clinical track of the Synthesis Practitioner Training Program, and developing group-based psychedelic integration programs to strengthen connectedness to self, others, and nature. Ros is committed to building structures to safeguard the ethical expansion of psychedelic therapy, and consults for Usona.